PICO Negative Pressure Wound Therapy
-
Recon
Smith+Nephew’s PICO™ 7 and PICO 14 Negative Pressure Wound Therapy Systems are the first systems indicated to aid in reducing the incidence of both deep and superficial incisional surgical site infections and dehiscence
LONDON, Jan. 24, 2022 /PRNewswire/ — Smith+Nephew (LSE:SN,NYSE:SNN), the global medical technology business, is pleased to announce new indications for use for…
Read More » -
Biologics
Study results demonstrate 74% reduction in surgical site infections with use of PICO™ Single use Negative Pressure Wound Therapy system
16 May 2017 Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, proudly supports results of an independent, randomised…
Read More »